$1.72
-0.01[-0.58%]
At close: Apr 26
$1.72
0[0.00%]
After Hours: 6:00PM EDT
Adial Pharmaceuticals
(NASDAQ:ADIL)Adial Pharmaceuticals Stock (NASDAQ:ADIL), Analyst Ratings, Price Targets, Predictions
Adial Pharmaceuticals Inc has a consensus price target of $3.67, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Brookline Capital, Maxim Group, and Brookline Capital on July 11, 2023, August 17, 2022, and October 13, 2021. With an average price target of $6 between Brookline Capital, Maxim Group, and Brookline Capital, there's an implied 248.84% upside for Adial Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Brookline Capital
Maxim Group
Litchfield Hills
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Adial Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/11/2023 | ADIL | Buy Now | Adial Pharmaceuticals | $1.72 | 248.84% | Brookline Capital | Kumaraguru Raja | → $150 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2022 | ADIL | Buy Now | Adial Pharmaceuticals | $1.72 | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 10/13/2021 | ADIL | Buy Now | Adial Pharmaceuticals | $1.72 | 597.67% | Brookline Capital | Kumaraguru Raja | — | Initiates | → Buy | Get Alert |
| 06/29/2021 | ADIL | Buy Now | Adial Pharmaceuticals | $1.72 | 190.7% | Litchfield Hills | — | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Adial Pharmaceuticals (ADIL)?
The latest price target for Adial Pharmaceuticals (NASDAQ: ADIL) was reported by Brookline Capital on July 11, 2023. The analyst firm set a price target for $6.00 expecting ADIL to rise to within 12 months (a possible 248.84% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Adial Pharmaceuticals (ADIL)?
The latest analyst rating for Adial Pharmaceuticals (NASDAQ: ADIL) was provided by Brookline Capital, and Adial Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Adial Pharmaceuticals (ADIL)?
There is no last upgrade for Adial Pharmaceuticals.
When was the last downgrade for Adial Pharmaceuticals (ADIL)?
The last downgrade for Adial Pharmaceuticals Inc happened on August 17, 2022 when Maxim Group changed their price target from N/A to N/A for Adial Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Adial Pharmaceuticals (ADIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adial Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adial Pharmaceuticals was filed on July 11, 2023 so you should expect the next rating to be made available sometime around July 11, 2024.
Is the Analyst Rating Adial Pharmaceuticals (ADIL) correct?
While ratings are subjective and will change, the latest Adial Pharmaceuticals (ADIL) rating was a reiterated with a price target of $0.00 to $6.00. The current price Adial Pharmaceuticals (ADIL) is trading at is $1.72, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.